NCT00014404View on ClinicalTrials.gov

Celecoxib in Treating Patients With Precancerous Lesions of the Mouth

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Primary Completion Date

January 31, 2006

Conditions
Head and Neck Cancer
Interventions
DRUG

celecoxib

Trial Locations (3)

10021

Memorial Sloan-Kettering Cancer Center, New York

Weill Medical College of Cornell University, New York

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014404 - Celecoxib in Treating Patients With Precancerous Lesions of the Mouth | Biotech Hunter | Biotech Hunter